GANX: Gain Therapeutics, Inc. Stock

by  •  • Comments Off on GANX: Gain Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 53.61
Enterprise Value ($M) 42.39
Book Value ($M) 12.58
Book Value / Share 0.70
Price / Book 4.26
NCAV ($M) 11.75
NCAV / Share 0.65
Price / NCAV 4.56

Profitability (mra)
Return on Invested Capital (ROIC) -1.64
Return on Assets (ROA) -1.04
Return on Equity (ROE) -1.47

Liquidity (mrq)
Quick Ratio 3.59
Current Ratio 3.59

Balance Sheet (mrq) ($M)
Current Assets 17.78
Assets 18.61
Liabilities 6.03
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.06
Operating Income -22.26
Net Income -22.27

Cash Flow Statement (mra) ($M)
Cash From Operations -18.87
Cash from Investing 10.22
Cash from Financing 12.64

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-02 31,575 120,897 26.12
2024-05-01 3,116 57,107 5.46
2024-04-30 4,379 5,512 79.44
2024-04-29 2,031 10,470 19.40

(click for more detail)

Similar Companies
FHTX – Foghorn Therapeutics Inc. FOLD – Amicus Therapeutics, Inc.
FULC – Fulcrum Therapeutics, Inc. GHRS – GH Research PLC
GLYC – GlycoMimetics, Inc.


Financial data and stock pages provided by
Fintel.io